Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.

MLA

Blanken, Maarten O., et al. “Cost-Effectiveness of Rule-Based Immunoprophylaxis against Respiratory Syncytial Virus Infections in Preterm Infants.” European Journal of Pediatrics, vol. 177, no. 1, Jan. 2018, pp. 133–44. EBSCOhost, https://doi.org/10.1007/s00431-017-3046-1.

APA

Blanken, M. O., Frederix, G. W., Nibbelke, E. E., Koffijberg, H., Sanders, E. A. M., Rovers, M. M., Bont, L., on behalf of the Dutch RSV Neonatal Network, & Dutch RSV Neonatal Network. (2018). Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants. European Journal of Pediatrics, 177(1), 133–144. https://doi.org/10.1007/s00431-017-3046-1

Chicago

Blanken, Maarten O., Geert W. Frederix, Elisabeth E. Nibbelke, Hendrik Koffijberg, Elisabeth A. M. Sanders, Maroeska M. Rovers, Louis Bont, on behalf of the Dutch RSV Neonatal Network, and Dutch RSV Neonatal Network. 2018. “Cost-Effectiveness of Rule-Based Immunoprophylaxis against Respiratory Syncytial Virus Infections in Preterm Infants.” European Journal of Pediatrics 177 (1): 133–44. doi:10.1007/s00431-017-3046-1.